{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:44:55Z","timestamp":1791535495892,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":508,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jcmg.2011.11.021","type":"journal-article","created":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T20:30:21Z","timestamp":1334003421000},"page":"370-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":375,"title":["Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"5","author":[{"given":"John J.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2011.11.021_bib1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jcmg.2011.11.021_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11897-009-0020-x","article-title":"Imaging techniques in the evaluation and management of hypertrophic cardiomyopathy","volume":"6","author":"Kelley-Hedgepeth","year":"2009","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jcmg.2011.11.021_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jacc.2008.11.069","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bmj.332.7552.1251","article-title":"Management of hypertrophic cardiomyopathy","volume":"332","author":"Spirito","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jcmg.2011.11.021_bib5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMp038122","article-title":"Assessing risk in hypertrophic cardiomyopathy","volume":"349","author":"Cannon","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmg.2011.11.021_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcmg.2011.11.021_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2008.04.047","article-title":"Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"52","author":"Olivotto","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib8","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/S0735-1097(02)02602-5","article-title":"Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy","volume":"40","author":"Choudhury","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10554-008-9292-6","article-title":"Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study","volume":"24","author":"Kwon","year":"2008","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2011.11.021_bib12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/eurheartj\/ehp152","article-title":"Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy","volume":"30","author":"Leonardi","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2011.11.021_bib13","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib14","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","article-title":"Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy","volume":"51","author":"Wu","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","article-title":"Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy","volume":"56","author":"Bruder","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","article-title":"Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy","volume":"3","author":"Rubinshtein","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jcmg.2011.11.021_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.108.768119","article-title":"Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy","volume":"1","author":"Maron","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jcmg.2011.11.021_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1532-429X-10-35","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols","volume":"10","author":"Kramer","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2011.11.021_bib20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jacc.2010.06.004","article-title":"Prognosis in hypertrophic cardiomyopathy with contrast-enhanced cardiac magnetic resonance: the future looks bright","volume":"56","author":"Salerno","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib21","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mri.2010.03.031","article-title":"Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease","volume":"29","author":"Bello","year":"2010","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.jcmg.2011.11.021_bib23","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jacc.2004.12.057","article-title":"Infarct morphology identifies patients with substrate for sustained ventricular tachycardia","volume":"45","author":"Bello","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1540-8167.2009.01503.x","article-title":"Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial","volume":"20","author":"Kadish","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib25","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2008.06.049","article-title":"Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping","volume":"52","author":"Iles","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.11.021_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","article-title":"Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans","volume":"122","author":"Flett","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.11.021_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2005.02.050","article-title":"Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy","volume":"151","author":"Sorajja","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcmg.2011.11.021_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1532-429X-11-43","article-title":"Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry","volume":"11","author":"Wagner","year":"2009","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X12001659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X12001659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:39:28Z","timestamp":1761845968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X12001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1936878X12001659"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2011.11.021","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2011.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}